Pharma giant GSK to build Singapore facility making Hepatitis B vaccine | Video
02:37 Min
Pharmaceutical firm GSK is building a new S$343 million manufacturing facility in Singapore for Hepatitis B vaccines. The British company is also moving its entire vaccine production here. Sherlyn Seah with more.
13 Jul 2023 11:11pm
Pharmaceutical firm GSK is building a new S$343 million manufacturing facility in Singapore for Hepatitis B vaccines. The British company is also moving its entire vaccine production here. Sherlyn Seah with more.
Popular Shows
